OneSource Specialty Pharma Ltd
ONESOURCE
Company Profile
Business description
OneSource Specialty Pharma Ltd is engaged in the research, development, manufacture, and commercialization of biological drug products in different injectable formats. The company also offers end-to-end CDMO services across all phases of pre-clinical and clinical development and commercial supply of biologics. The company’s reportable segments are Unit 1 - R&D and Unit 2 : CDMO-1 (Contract Development & Manufacturing Organization); and Unit 3: Multimodal Facility and CDMO-2.
Contact
Bannerghatta Road
Star 1, Opp IIM Bangalore
Bilekahalli
BangaloreKA560076
INDT: +91 8067840738
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 March 2026
Employees
Stocks News & Analysis
stocks
A collection of our best stock opportunities
Our latest articles about where we see opportunities in the market.
stocks
Morningstar analyst reacts to Macquarie Group’s earnings
Banking Analyst Nathan Zaia’s analysis of MQG’s results.
stocks
Undervalued ASX share showing progress in global efforts
More clarity on the path forward in the UK.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,983.30 | 16.60 | 0.19% |
| CAC 40 | 7,857.36 | 56.48 | 0.72% |
| DAX 40 | 24,217.37 | 247.01 | 1.03% |
| Dow JONES (US) | 44,632.99 | 204.57 | -0.46% |
| FTSE 100 | 9,136.32 | 54.88 | 0.60% |
| HKSE | 25,524.45 | 37.68 | -0.15% |
| NASDAQ | 21,098.29 | 80.29 | -0.38% |
| Nikkei 225 | 40,611.27 | 63.28 | -0.16% |
| NZX 50 Index | 12,955.63 | 19.22 | 0.15% |
| S&P 500 | 6,370.86 | 18.91 | -0.30% |
| S&P/ASX 200 | 8,724.40 | 19.80 | 0.23% |
| SSE Composite Index | 3,609.45 | 0.27 | -0.01% |